DYNE THERAPEUTICS INC (DYN)

US26818M1080 - Common Stock

26.08  +0.08 (+0.31%)

After market: 26.08 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
242.16M170.96M150.03M58.65M13.83M
Research and Development
210.76M142.76M121.31M45.20M11.04M
Selling, General, and Administrative Expenses
31.40M28.20M28.72M13.45M2.79M
Operating Income
-242.16M-170.96M-150.03M-58.65M-13.83M
Interest Income/Expense
7.64M2.92M740.00K-340.00K290.00K
Other Income/Expense
-1.42M-50.00K-10.00K-450.00K-1.32M
Income Before Taxes
-235.94M-168.10M-149.29M-59.44M-14.86M
Net Income
-235.94M-168.10M-149.29M-59.44M-14.86M
EBITDA
-240.49M-169.28M-148.94M-57.95M-13.56M
 
Per Share Data
EPS Diluted Total Ops
-3.95-3.23-2.93-1.32-0.34
Non GAAP EPS
-3.94-3.24-2.91N/AN/A
 
Statistics

All data in USD

Charts